The RESILIENT Study: A Retrospective, Descriptive, Correlational Investigation of Correlates of Oral Endocrine Therapy Adherence in Older Women With Breast Cancer
Cancer Medicine · 2026-05 · 15 (5)
DOI: 10.1002/cam4.71925 ↗At a glance
Journal article in Cancer Medicine, published online on 2026-05-08. Written by Sunny Y Ruggeri and 5 co-authors. Institution: Solomont School of Nursing, Zuckerberg College of Health Science, University of Massachusetts Lowell, Lowell, Massachusetts, USA. Major MEDLINE topics: Breast Neoplasms, Antineoplastic Agents, Hormonal, Drug Monitoring, Medication Adherence. 147 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCI NIH HHS, Sigma Theta Tau Lambda Phi Chapter, Worcester State Foundation.
Abstract (original language)
Background
Breast cancer is the most prevalent and costly cancer. Oral endocrine therapy (OET) improves survival rates and quality of life while reducing recurrence, mortality, morbidity, and medical costs. However, adherence to OET is challenging because OET is prescribed for 5–10 years. Determinants of OET nonadherence (NA) among women aged 65 and older remain poorly characterized. Existing studies are limited, often focusing on small, single‐site samples and focusing on patient‐level rather than multi‐level determinants. Despite the unique needs of older women, research on OET‐NA remains scarce.
Objective
This study identified multi‐level determinants of OET‐NA in older women using ecological systems theory and the World Health Organization's five‐dimension model.
Methods
A descriptive, correlational secondary data analysis was conducted using the 2019 Surveillance‐Epidemiology‐End‐Results (SEER) Medicare database, which includes more than 9 million cancer cases in the United States.
Result
OET‐NA was significantly affected by (a) patient‐related factors of ethnicity (i.e., Black [AOR 1.55; 95% CI 1.34–1.78; p < 0.001]) and psychological issues (i.e., depression [OR 1.40; 95% CI 1.27–1.54; p < 0.001]), (b) socioeconomic‐related factors of marital status (i.e., divorced [OR 1.17; 95% CI 1.04–1.32; p ≤ 0.01]), and lifestyle (i.e., tobacco use [OR 1.41; 95% CI 1.22–1.63; p < 0.001]), (c) therapy‐related factors of switching OET medications (OR 2.72; 95% CI 2.41–3.07; p < 0.001), (d) condition‐related factors of comorbidities (i.e., obesity [OR 1.13; 95% CI 1.03–1.23; p < 0.01]), and (e) characteristics of the healthcare team and health system‐related factors (i.e., group practice type [OR 1.26; 95% CI 1.01–1.56; p < 0.05]).
Conclusion
OET‐NA was associated with multi‐level determinants, including being Black, having depression, being divorced, using tobacco, switching OET medications, having obesity, and receiving care in group practices. Identifying these determinants is a critical first step toward developing and testing interventions to improve OET‐NA and enhance survival and quality of life.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Solomont School of Nursing, Zuckerberg College of Health Science, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
- School of Nursing and Health Studies, University of Missouri-Kansas City, Kansas City, Missouri, USA.
- School of Nursing, Columbia University, New York, New York, USA.
- School of Nursing, Indiana University, Indianapolis, Indiana, USA.
- Children's Mercy Kansas City, Kansas City, Missouri, USA.
ORCID profiles: Sunny Y Ruggeri, Cynthia L Russell Lippincott, Gregory L Alexander, Rebecca J Bartlett Ellis, Steven R Chesnut, Lori A Erickson
Funding
- NCI NIH HHS
- Sigma Theta Tau Lambda Phi Chapter
- Worcester State Foundation
- University of Missouri Kansas City Women's Council
- Bridgeport Hospital School of Nursing Alumni Association
- University of Massachusetts Lowell
Cite
APA
Ruggeri, S. Y., Russell Lippincott, C. L., Alexander, G. L., Bartlett Ellis, R. J., Chesnut, S. R., & Erickson, L. A. (2026). The RESILIENT Study: A Retrospective, Descriptive, Correlational Investigation of Correlates of Oral Endocrine Therapy Adherence in Older Women With Breast Cancer. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71925
Vancouver
Ruggeri SY, Russell Lippincott CL, Alexander GL, Bartlett Ellis RJ, Chesnut SR, Erickson LA. The RESILIENT Study: A Retrospective, Descriptive, Correlational Investigation of Correlates of Oral Endocrine Therapy Adherence in Older Women With Breast Cancer. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71925
BibTeX
@article{Ruggeri2026,
author = {Ruggeri, Sunny Y and Russell Lippincott, Cynthia L and Alexander, Gregory L and Bartlett Ellis, Rebecca J and Chesnut, Steven R and Erickson, Lori A},
title = {The RESILIENT Study: A Retrospective, Descriptive, Correlational Investigation of Correlates of Oral Endocrine Therapy Adherence in Older Women With Breast Cancer},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {5},
doi = {10.1002/cam4.71925}
}
EUVIMED